Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: 10-Year Experience From a US-Based Registry.

Matsson, Anton; Solomon, Daniel H; Crabtree, Margaux M; Harrison, Ryan W; Litman, Heather J; Johansson, Fredrik D

Matsson, Anton; Solomon, Daniel H; Crabtree, Margaux M; Harrison, Ryan W; Litman, Heather J; Johansson, Fredrik D.

Afiliação

Matsson A; Chalmers University of Technology, Gothenburg, Sweden.
Solomon DH; Brigham and Women's Hospital, Boston, Massachusetts.
Crabtree MM; (current address: Biogen Inc., Cambridge, Massachusetts), CorEvitas, LLC, Waltham, Massachusetts.
Harrison RW; (current address: Biogen Inc., Cambridge, Massachusetts), CorEvitas, LLC, Waltham, Massachusetts.
Litman HJ; (current address: Biogen Inc., Cambridge, Massachusetts), CorEvitas, LLC, Waltham, Massachusetts.
Johansson FD; Chalmers University of Technology, Gothenburg, Sweden.

ACR Open Rheumatol ; 6(1): 5-13, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37885052

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACR Open Rheumatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google